Clinical Trial Update: Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and tolerability of olaparib tablets in Japanese patients with advanced solid malignancies has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Malignancies

Drugs mentioned

• Olaparib (Olaparib)

Snippet

Sponsor: AstraZeneca | Conditions: Cancer, Advanced Solid Malignancies | Phase 1 | Status: COMPLETED | Results posted: 2017-12-12